SOX9 and neoplasm: Compared to untreated cells (Figure 3C) or tumor cells treated with rabbit IgG negative control (Figure 3D), tumor cells treated with anti-KRAS antibody showed weaker SOX9 cytoplasmic staining and less nuclear localization (Figure 3E).